Sofinnova Venture Partners IX, L.P. Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sofinnova Venture Partners IX, L.P..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sofinnova Venture Partners IX, L.P.. Sofinnova Venture Partners IX, L.P. is 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in NextCure, Inc. ($NXTC) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX).

Latest Insider Trading Transactions of Sofinnova Venture Partners IX, L.P.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, LIFE, ETTX, ITRM, NXTC

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 03 2020	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Sell	S	1.61	400,000	642,960	1,226,514	1.6 M to 1.2 M (-24.59 %)
Jun 03 2020	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Sell	S	1.69	100,000	169,120	1,626,514	1.7 M to 1.6 M (-5.79 %)
Nov 19 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Buy	P	36.75	150,000	5,512,500	2,671,856	2.5 M to 2.7 M (+5.95 %)
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	3,773,585	0	0
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	7,301,000	0	0
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	3,732,500	0	0
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	2,239,500	0	0
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Buy	P	15.00	400,000	6,000,000	2,521,856	2.1 M to 2.5 M (+18.85 %)
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	469,713	0	2,121,856	1.7 M to 2.1 M (+28.43 %)
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	908,785	0	1,652,143	743.4 K to 1.7 M (+122.25 %)
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	464,599	0	743,358	278.8 K to 743.4 K (+166.67 %)
May 15 2019	NXTC	NextCure, Inc.	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	278,759	0	278,759	0 to 278.8 K
Oct 02 2018	ETTX	Entasis Therapeuti ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	9,502,249	0	0
Oct 02 2018	ETTX	Entasis Therapeuti ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	7,446,904	0	0
Oct 02 2018	ETTX	Entasis Therapeuti ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	P	15.00	337,724	5,065,860	1,180,178	842.5 K to 1.2 M (+40.09 %)
Oct 02 2018	ETTX	Entasis Therapeuti ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	458,425	0	842,454	384 K to 842.5 K (+119.37 %)
Oct 02 2018	ETTX	Entasis Therapeuti ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	359,267	0	359,267	0 to 359.3 K
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	229,660	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	275,446	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	229,660	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	721,408	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	275,446	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	P	13.00	500,000	6,500,000	1,726,514	1.2 M to 1.7 M (+40.77 %)
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	721,408	0	0
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	229,660	0	1,226,514	996.9 K to 1.2 M (+23.04 %)
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	P	13.00	500,000	6,500,000	1,726,514	1.2 M to 1.7 M (+40.77 %)
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	275,446	0	996,854	721.4 K to 996.9 K (+38.18 %)
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	229,660	0	1,226,514	996.9 K to 1.2 M (+23.04 %)
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	721,408	0	721,408	0 to 721.4 K
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	275,446	0	996,854	721.4 K to 996.9 K (+38.18 %)
May 30 2018	ITRM	Iterum Therapeutic ...	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	721,408	0	721,408	0 to 721.4 K
May 14 2015	LIFE	aTYR PHARMA INC	Sofinnova Venture Partners IX, ...	10% Owner	Option Exercise	C	0.00	14,968,722	0	0
May 14 2015	LIFE	aTYR PHARMA INC	Sofinnova Venture Partners IX, ...	10% Owner	Buy	P	14.00	320,000	4,480,000	1,866,126	1.5 M to 1.9 M (+20.70 %)
May 14 2015	LIFE	aTYR PHARMA INC	Sofinnova Venture Partners IX, ...	10% Owner	Buy	C	0.00	1,546,126	0	1,546,126	0 to 1.5 M

Page: 1